SCHEMBL25916338

SCHEMBL25916338

COc1ccc(-c2nc3ccccc3s2)c(NC(=O)/C=C/c2ccccc2)c1

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
FSCN1 Q16658 1/20 0.56
MAPT P10636 10/20 0.56
TP53 P04637 5/20 0.56
LMNA P02545 1/20 0.56
RXFP1 Q9HBX9 3/20 0.54
SMN1; SMN2 Q16637 3/20 0.53
NPC1 O15118 2/20 0.53
RAB9A P51151 2/20 0.53
MAOB P27338 1/20 0.52
ADORA2A P29274 1/20 0.52
ADORA2B P29275 1/20 0.52
MMP1 P03956 3/20 0.51
MMP2 P08253 3/20 0.51
MMP9 P14780 3/20 0.51
EGFR P00533 2/20 0.51
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
DYRK1A Q13627 2/20 0.49
TRPA1 O75762 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30362725 1.00 FSCN1 (0.56) FSCN1MAPTTP53LMNARXFP1
SCHEMBL29126276 1.00 FSCN1 (0.56) FSCN1MAPTTP53LMNARXFP1
SCHEMBL29126275 1.00 FSCN1 (0.56) FSCN1MAPTTP53LMNARXFP1
SCHEMBL29126291 0.93 MAPT (0.57) FSCN1MAPTTP53LMNARXFP1
SCHEMBL25916316 0.93 MAPT (0.57) FSCN1MAPTTP53LMNARXFP1
SCHEMBL30362551 0.93 MAPT (0.57) FSCN1MAPTTP53LMNARXFP1
SCHEMBL29126289 0.93 MAPT (0.57) FSCN1MAPTTP53LMNARXFP1
SCHEMBL29126274 0.85 FSCN1 (0.66) FSCN1MAPTTP53LMNARXFP1
SCHEMBL29126272 0.85 FSCN1 (0.66) FSCN1MAPTTP53LMNARXFP1
SCHEMBL25916304 0.85 FSCN1 (0.66) FSCN1MAPTTP53LMNARXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230235190-A1 FLUORESCENT COMPOSITION COMPRISING AT LEAST ONE BENZAZOLE COMPOUND FOR THE SECUREMENT OF PRODUCTS Crime Science Technology (FR) 2023-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230235190-A1 FLUORESCENT COMPOSITION COMPRISING AT LEAST ONE BENZAZOLE COMPOUND FOR THE SECUREMENT OF PRODUCTS TUBB3, TUBA3C, PHB1 FSCN1 795/4885MAPT 318/4885TP53 905/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.